Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners

Close

Posts by Paul Hatton

Paul is a Managing Director responsible for Business Development for ICR Westwicke. He is involved in the origination of new business opportunities in Healthcare Investor Relations and Public Relations, as well as outreach with private equity and venture capital firms focused on Healthcare. He joined the firm following a 30-year career on Wall Street focused on Capital Markets and Corporate Finance.

Is 2024 the Year for the Life Science IPO Market?

Posted on February 27th, 2024. Posted by

Woman,Laborant,Working,With,Microscope,Holding,Automatic,Pipette

Since November 2023, the IPO market for companies has shown some signs of life – dare we say, “green shoots.”  Over the most recent 15-week period, 10 firms transition to their new chapters as publicly listed companies. In 8 of the 10 cases, the stock price has risen above the new issue price, with notable increases from Cargo Therapeutics (“CRGX”) +55.0%; Arrivent Biopharma (“AVBP”) + 28.9%; and CG Oncology (“CGON”) + 129.5% (as of EOD, February 23). Continue Reading

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?”

Our Locations